Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSCT with Chemotherapy-Only Conditioning for Fanconi Anemia
NCT01071239Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Apr 2009
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, cyclophosphamide, fludarabine, antithymocyte globulin rabbit in Fanconi anemia (FA), sponsored by Medical College of Wisconsin. Started Apr 2009; status: completed.
02
Drugs
busulfancyclophosphamidefludarabineantithymocyte globulin rabbit
03
Conditions
Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT01071239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071239.